Latest BRAF Stories
SOUTH SAN FRANCISCO, Calif., Feb.
- Array to receive global rights from Novartis to innovative BRAF inhibitor - BOULDER, Colo., Jan. 23, 2015 /PRNewswire/ -- Array BioPharma Inc.
ReportsnReports.com adds "Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023" to its store.
ReportsnReports.com adds “Colorectal Cancer – US Drug Forecast and Market Analysis to 2023” to its store.
SAN DIEGO, Dec. 4, 2014 /PRNewswire/ -- Trovagene, Inc.
SAN DIEGO, Nov. 6, 2014 /PRNewswire/ -- Trovagene, Inc.
Prospective blinded study demonstrates ability to accurately determine mutational status and monitor response to BRAF inhibitor therapy from urinary cell-free DNA SAN DIEGO, Oct.
NEW YORK, Oct.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.